Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 24, 1994 - Issue 6
6
Views
10
CrossRef citations to date
0
Altmetric
Research Article

C-raf expression in early rat liver tumorigenesis after promotion with polychlorinated biphenyls or phenobarbital

, &
Pages 569-580 | Received 18 Nov 1993, Accepted 28 Feb 1994, Published online: 22 Sep 2008
 

Abstract

1. The expression of c-raf protooncogene in early stages of chemically induced rat liver tumorigenesis was studied in weanling female and adult male Sprague-Dawley rats. After initiation with diethylnitrosamine, promotion by polychlorinated biphenyls (PCBs) or phenobarbital (PB) was studied in the female. Male rats were promoted with PCBs only.

2. The incidence of enzyme-altered foci was evaluated histochemically by demonstrating a deficiency in adenosine-5′-triphosphatase and the emergence of γ-glutamyl-transpeptidase. C-raf expression was measured in liver tissue containing preneoplastic foci, and in small (> 3 mm in diameter) and large (< 3 mm in diameter) neoplastic nodules up to 36 weeks.

3. Foci numbers amounted to 60-70 per cm2 liver section with both histochemical markers and both promoters in female rats. In male rats foci numbers were about 20—40 per cm2 liver section with both markers and with PCBs as promoting agents. Foci area developed more rapidly in female rats.

4. Small and large nodules were found in females during the entire observation period with both promoting agents, PCBs being more effective than PB. C-raf expression in nodules was increased up to 10-fold in PCB-treated animals compared with untreated controls. No dependence on the size of the nodules was seen. In male rats nodule incidence was very low and c-raf induction was marginal.

5. In conclusion, c-raf proto-oncogene expression correlated with the incidence of foci and nodules, female rats being more sensitive than males.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.